Shield Therapeutics plc: Composition of Matter Patent Granted on Feraccru(R) -- New patent adds significant protection to Feraccru® and extends exclusivity until at least 2034 -- LONDON, Sept. 7, 2016 (GLOBE NEWSWIRE) -- Shield Therapeutics plc (LSE:STX), a...